Modifier effect of ENOS in autosomal dominant polycystic kidney disease
- PMID: 11823442
- DOI: 10.1093/hmg/11.3.229
Modifier effect of ENOS in autosomal dominant polycystic kidney disease
Abstract
A significant phenotypical variability is observed in autosomal dominant polycystic kidney disease (ADPKD). ADPKD is associated with altered endothelial-dependent vasodilation and decreased vascular production of nitric oxide (NO). Thus, ENOS, the gene coding for the endothelial nitric oxide synthase (eNOS), could have a modifier effect in ADPKD. In order to test this hypothesis, we genotyped 173 unrelated ADPKD patients from Belgium and the north of France for the Glu298Asp, intron 4 VNTR and T-786C polymorphisms of ENOS and looked for their influence on the age at end-stage renal disease (ESRD). In males (n = 93), the Glu298Asp polymorphism was associated with a lower age at ESRD (Glu/Asp + Asp/Asp: 49.0 +/- 1.2 years, n = 53; Glu/Glu: 53.5 +/- 1.5 years, n = 40; simple regression, P = 0.02; multiple regression, P = 0.006). This effect was confirmed in a subset of males linked to PKD1 and reaching ESRD before age 45, and by a cumulative renal survival analysis in PKD1-linked families. Further studies demonstrated that NO synthase (NOS) activity was decreased in renal artery samples from ADPKD males harbouring the Asp298 allele, in association with post-translational modifications and partial cleavage of eNOS. No significant effect of the other polymorphisms was found in males, and no polymorphism influenced the age at ESRD in females. In conclusion, the frequent Glu298Asp polymorphism of ENOS is associated with a 5 year lower mean age at ESRD in this subset of ADPKD males. This effect could be due to a decreased NOS activity and a partial cleavage of eNOS, leading to a further decrease in the vascular production of NO.
Similar articles
-
The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.Ren Fail. 2004 Mar;26(2):119-25. doi: 10.1081/jdi-120038485. Ren Fail. 2004. PMID: 15287194
-
Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.Nephrology (Carlton). 2014 Oct;19(10):630-7. doi: 10.1111/nep.12310. Nephrology (Carlton). 2014. PMID: 24995932 Review.
-
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.Am J Kidney Dis. 2003 Jan;41(1):90-4. doi: 10.1053/ajkd.2003.50027. Am J Kidney Dis. 2003. PMID: 12500225
-
Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.Kidney Blood Press Res. 2002;25(2):87-90. doi: 10.1159/000063513. Kidney Blood Press Res. 2002. PMID: 12077489
-
Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?J Nephrol. 2003 May-Jun;16(3):449-52. J Nephrol. 2003. PMID: 12832751 Review.
Cited by
-
NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients.J Bras Nefrol. 2022 Apr-Jun;44(2):224-231. doi: 10.1590/2175-8239-JBN-2021-0089. J Bras Nefrol. 2022. PMID: 35138322 Free PMC article.
-
Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury.Am J Pathol. 2007 Jan;170(1):87-99. doi: 10.2353/ajpath.2007.060610. Am J Pathol. 2007. PMID: 17200185 Free PMC article.
-
Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).Biochim Biophys Acta. 2011 Oct;1812(10):1327-36. doi: 10.1016/j.bbadis.2011.06.012. Epub 2011 Jul 1. Biochim Biophys Acta. 2011. PMID: 21745567 Free PMC article. Review.
-
Prevalence of endothelial nitric oxide synthase (ENOS) gene G894T polymorphism and its association with hypertension: a population-based study with Brazilian women.Arch Med Sci Atheroscler Dis. 2019 Apr 18;4:e63-e73. doi: 10.5114/amsad.2019.84539. eCollection 2019. Arch Med Sci Atheroscler Dis. 2019. PMID: 31211272 Free PMC article.
-
The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population.Mol Biol Rep. 2012 Mar;39(3):3245-9. doi: 10.1007/s11033-011-1092-8. Epub 2011 Jun 25. Mol Biol Rep. 2012. PMID: 21706163
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources